文献速递心脑血管急症重症综合管理与镇静镇痛

重型创伤性脑损伤脑氧优化二期试验:一项二期随机试验

Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase-II: A Phase II Randomized Trial.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论在重型创伤性脑损伤中,基于颅内压联合脑组织氧分压监测的分层治疗方案较单纯颅内压监测减少脑组织缺氧时间比例(0.16 vs 0.45,P<0.0001),死亡率有降低趋势但研究未以临床疗效为效能目标。

该研究为美国10个ICU开展的前瞻性随机二期试验,纳入119例重型创伤性脑损伤患者,随机分为颅内压联合脑组织氧分压监测指导治疗组与单纯颅内压监测组(后者脑组织氧分压数据盲法记录)。结果显示联合监测组脑组织缺氧时间比例显著低于单纯颅内压组(0.16 vs 0.45,P<0.0001),两组颅内压控制相似,分层治疗方案安全可行且无操作相关并发症。联合监测组死亡率降低、良好恢复比例增加,但研究未以临床疗效为效能目标。作者认为需开展三期随机试验评估颅内压联合脑组织氧分压指导治疗对神经功能结局的影响。

要点

  • 重型创伤性脑损伤患者采用颅内压联合脑组织氧分压监测指导的分层治疗,脑组织缺氧时间比例为0.16,单纯颅内压监测组为0.45(P<0.0001)。
  • 两组颅内压控制相似,联合监测的分层治疗方案安全性和可行性得到确认,无操作相关并发症。
  • 联合监测组死亡率降低、良好恢复比例增加,但研究未以临床疗效为效能目标。
  • 监测探头在连续48小时数值正常后或5天后移除。
  • 作者认为需开展三期随机试验评估该方案对神经功能结局的影响。

适用人群与场景

  • 美国10个ICU收治的119例重型创伤性脑损伤患者。

诊断标准与关键阈值

  • 监测探头移除标准:连续48小时数值正常,或监测满5天后移除。

处置流程与药物剂量

  • 患者随机接受基于颅内压联合脑组织氧分压监测的治疗方案,或仅基于颅内压监测的治疗方案;单纯颅内压组脑组织氧分压数据以盲法记录。
  • 各治疗组均预设分层干预措施,并测量其对颅内压和脑组织氧分压的影响。
  • 监测探头在连续48小时数值正常后或5天后移除。
  • 结局在6个月时采用扩展格拉斯哥结局量表评估。

研究设计与关键结果

  • 研究类型:前瞻性随机二期临床试验,美国10个ICU,纳入119例重型创伤性脑损伤患者。
  • 干预与对照:颅内压联合脑组织氧分压监测指导治疗组 vs 单纯颅内压监测组(后者脑组织氧分压数据盲法记录)。
  • 主要结果:联合监测组脑组织缺氧时间比例为0.16,单纯颅内压组为0.45(P<0.0001)。
  • 两组颅内压控制相似;分层治疗方案的安全性和可行性得到确认,无操作相关并发症。
  • 联合监测组死亡率降低、良好恢复比例增加,但研究未以临床疗效为效能目标。
  • 结局于6个月时采用扩展格拉斯哥结局量表评估。

证据类型、等级与局限

  • 证据类型:前瞻性随机二期临床试验。
  • 局限:研究未以临床疗效为效能目标;作者认为需开展三期随机试验评估对神经功能结局的影响。

对床旁实践的改变

  • 在重型创伤性脑损伤中,颅内压联合脑组织氧分压监测指导的分层治疗可减少脑组织缺氧时间比例(0.16 vs 0.45),且不增加操作相关并发症。
  • 联合监测组死亡率降低和良好恢复比例增加仅为趋势,研究未以临床疗效为效能目标,作者认为需三期随机试验进一步评估。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: A relationship between reduced brain tissue oxygenation and poor outcome following severe traumatic brain injury has been reported in observational studies. We designed a Phase II trial to assess whether a neurocritical care management protocol could improve brain tissue oxygenation levels in patients with severe traumatic brain injury and the feasibility of a Phase III efficacy study.

DESIGN: Randomized prospective clinical trial.

SETTING: Ten ICUs in the United States.

PATIENTS: One hundred nineteen severe traumatic brain injury patients.

INTERVENTIONS: Patients were randomized to treatment protocol based on intracranial pressure plus brain tissue oxygenation monitoring versus intracranial pressure monitoring alone. Brain tissue oxygenation data were recorded in the intracranial pressure -only group in blinded fashion. Tiered interventions in each arm were specified and impact on intracranial pressure and brain tissue oxygenation measured. Monitors were removed if values were normal for 48 hours consecutively, or after 5 days. Outcome was measured at 6 months using the Glasgow Outcome Scale-Extended.

MEASUREMENTS AND MAIN RESULTS: A management protocol based on brain tissue oxygenation and intracranial pressure monitoring reduced the proportion of time with brain tissue hypoxia after severe traumatic brain injury (0.45 in intracranial pressure-only group and 0.16 in intracranial pressure plus brain tissue oxygenation group; p < 0.0001). Intracranial pressure control was similar in both groups. Safety and feasibility of the tiered treatment protocol were confirmed. There were no procedure-related complications. Treatment of secondary injury after severe traumatic brain injury based on brain tissue oxygenation and intracranial pressure values was consistent with reduced mortality and increased proportions of patients with good recovery compared with intracranial pressure-only management; however, the study was not powered for clinical efficacy.

CONCLUSIONS: Management of severe traumatic brain injury informed by multimodal intracranial pressure and brain tissue oxygenation monitoring reduced brain tissue hypoxia with a trend toward lower mortality and more favorable outcomes than intracranial pressure-only treatment. A Phase III randomized trial to assess impact on neurologic outcome of intracranial pressure plus brain tissue oxygenation-directed treatment of severe traumatic brain injury is warranted.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Okonkwo DO, Shutter LA, Moore C, et al. Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase-II: A Phase II Randomized Trial. Crit Care Med. 2017. PMID: 29028696. doi:10.1097/CCM.0000000000002619

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。